Effect of Shakuyakukanzoto on Chemotherapy-Induced Hiccups in Patients with Lung Cancer.

Herbal medicine drug therapy hiccup lung neoplasms

Journal

The Eurasian journal of medicine
ISSN: 1308-8734
Titre abrégé: Eurasian J Med
Pays: Turkey
ID NLM: 101557701

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 12 04 2018
accepted: 25 06 2018
entrez: 15 3 2021
pubmed: 16 3 2021
medline: 16 3 2021
Statut: ppublish

Résumé

Shakuyakukanzoto, one of the traditional herbal medicines commonly used in North-East Asian countries, is known to be effective for muscle cramps. This retrospective study aimed to evaluate the effect of shakuyakukanzoto on chemotherapy-induced metoclopramide-uncontrolled hiccups. We retrospectively investigated the medical records of all the consecutive patients with lung cancer who were prescribed with shakuyakukanzoto (Tsumura Co. Tokyo, Japan) for chemotherapy-induced hiccups in our hospital from September 2013 to November 2017. In the medical record from the initiation of shakuyakukanzoto until the start of the next chemotherapy, when there was description of "complete or partial disappearance of hiccups" after the prescription of shakuyakukanzoto, it was judged as a complete or partial response. A statement of "unchanged," no description of improvement, or exacerbation was judged as no change. Of the 49 chemotherapy courses in 15 patients with lung cancer, 93.9% had a "partial or complete" response within a few hours after the administration of shakuyakukanzoto. The effect of shakuyakukanzoto was observed irrespective of the pathological type of lung cancer, platinum-containing or non-platinum chemotherapy, and with or without other anti-hiccup drugs. No adverse event was observed. Shakuyakukanzoto may offer an effective pharmacological approach to treat chemotherapy-induced metoclopramide-uncontrolled hiccups. Well-planned prospective studies will confirm our results.

Identifiants

pubmed: 33716521
doi: 10.5152/eurasianjmed.2020.18184
pii: eajm-53-1-2
pmc: PMC7929594
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2-4

Informations de copyright

©Copyright 2021 by the Atatürk University School of Medicine - Available online at www.eurasianjmed.com.

Déclaration de conflit d'intérêts

Conflict of Interest: The authors declared no conflicts of interest.

Références

Gynecol Oncol. 2001 May;81(2):333-4
pubmed: 11330975
Pharmacotherapy. 1996 Nov-Dec;16(6):986-95
pubmed: 8947969
Support Care Cancer. 2009 Mar;17(3):315-20
pubmed: 18839222
Gan To Kagaku Ryoho. 2017 Jan;44(1):63-65
pubmed: 28174382
Gut. 2005 Oct;54(10):1503-4
pubmed: 16162960
Am J Chin Med. 2003;31(3):445-53
pubmed: 12943175
J Nat Med. 2015 Jul;69(3):287-95
pubmed: 25783410
Nephron Clin Pract. 2006;104(1):c28-32
pubmed: 16685141
Fukushima J Med Sci. 2014;60(1):22-30
pubmed: 24670676
J Natl Cancer Inst. 2002 May 15;94(10):772
pubmed: 12011230
Clin Neuropharmacol. 2010 Jul;33(4):179-80
pubmed: 20414106
J Ethnopharmacol. 2013 Jan 9;145(1):286-93
pubmed: 23164761

Auteurs

Satoshi Kamoshida (S)

Department of Pharmacy, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Mito, Ibaraki, Japan.

Shinichiro Okauchi (S)

Department of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Mito, Ibaraki, Japan.

Hajime Osawa (H)

Department of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Mito, Ibaraki, Japan.

Gen Ohara (G)

Department of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Mito, Ibaraki, Japan.

Katsunori Kagohashi (K)

Department of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Mito, Ibaraki, Japan.

Hiroaki Satoh (H)

Department of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Mito, Ibaraki, Japan.

Classifications MeSH